title: Hemodialysis patients profile at Dow University of Health Sciences, Karachi. Pakistan.
abstract: OBJECTIVE
  To determine the frequency of diseases contributing to End Stage Renal Failure (ESRF) and to determine the frequency of seropositivity for hepatitis B and hepatitis C in our patients.
  
  
  METHODS
  This is an observational study of two years duration from January 2012 till December 2013, done at Dow university of Health Sciences. Sample size is 189 by convenient method. Data collection is retrospective. Inclusion criteria includes all patients ever hemodialysed at DIMC with age 14 or above. Exclusion criteria is age below 14. Data maintained and analyzed on SPSS version 16. All categorical data in percentages and numeric data is given in frequencies and mean with Standard deviation.
  
  
  RESULTS
  Total number of patients included in study were 189, Males were 94/189 (49.7%), females were 95/189 (50.3%), Male to female ratio was 0.98: 1.0. Mean age was 51.88+15.2, range was14-86 years. Patients started on Hemodialysis were found to have hypertension in 40.2%, both diabetes and hypertension was present in 42.8%, diabetes alone in 3.1% of patients as likely etiology of renal failure. Seropositivity for HBV was found 4/189(2.1%) and HCV in 31/189(16.4%) at initiation of Hemodialysis.
  
  
  CONCLUSIONS
  Hypertension alone is an important disease found in patients with renal failure as likely cause followed by diabetes. Hepatitis C positivity at start of hemodialysis is 16%.
authors: Dr. Huma Mamun Mahmud, MBBS, FCPS, Consultant Nephrologist, In Charge Hemodialysis Unit, DIMC, Ojha Campus, Dow International Medical College (Ojha Campus), DUHS, Suparco Road, off Main University Road, Gulzar-e-Hijri, Scheme 33, Karachi, Pakistan.
authors: Huma Mamun
authors: HM
authors: Mahmud
authors: Dr. Muneer Siddiqui, MBBS, FCPS, Dow International Medical College (Ojha Campus), DUHS, Suparco Road, off Main University Road, Gulzar-e-Hijri, Scheme 33, Karachi, Pakistan.
authors: Muneer
authors: M
authors: Siddiqui
authors: Dr. Babar Bashir, MBBS, FCPS, Dow International Medical College (Ojha Campus), DUHS, Suparco Road, off Main University Road, Gulzar-e-Hijri, Scheme 33, Karachi, Pakistan.
authors: Babar
authors: B
authors: Bashir
authors: Dr. Syed Farman Ali, Dow International Medical College (Ojha Campus), DUHS, Suparco Road, off Main University Road, Gulzar-e-Hijri, Scheme 33, Karachi, Pakistan.
authors: Syed Farman
authors: SF
authors: Ali
authors: Dr. Akhter Ali Baloch, Dow International Medical College (Ojha Campus), DUHS, Suparco Road, off Main University Road, Gulzar-e-Hijri, Scheme 33, Karachi, Pakistan.
authors: Akhter Ali
authors: AA
authors: Baloch
authors: Dr. Mohd Masroor, Dow International Medical College (Ojha Campus), DUHS, Suparco Road, off Main University Road, Gulzar-e-Hijri, Scheme 33, Karachi, Pakistan.
authors: Mohd
authors: M
authors: Masroor
keywords: Anti HCV; DUHS; ESRF; HBsAg; Hemodialysis